Healthcare Services

Genotyping Assay Market Size Outlook and Demand Growth Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Genotyping Assay Market Over The Period 2026–2030?

The genotyping assay market size has seen substantial growth in recent years. It is anticipated to expand from $41.31 billion in 2025 to $50.86 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.1%. The growth observed in the past can be credited to factors such as the advancement of PCR techniques, the rise of molecular diagnostics, the necessity for pharmaceutical safety testing, the early introduction of assays to the market, and the demand from academic research.

The genotyping assay market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $116.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.9%. Factors contributing to this growth during the forecast period include the rise in biomarker-driven drug development, greater automation in laboratories, the broadening of companion diagnostics, the need for rapid assays, and regulatory validation. Key trends for the upcoming period encompass a growing demand for SNP-based assays, wider adoption of PCR-based genotyping, the development of high-sensitivity genotyping assays, the broader use of genotyping assays in drug development, and the incorporation of automation in assay processing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

What Drivers Are Expected To Influence The Genotyping Assay Market During The Forecast Period?

The rising occurrence of genetic disorders is anticipated to fuel the expansion of the genotyping assay market in the future. Genetic disorders are health conditions resulting from irregularities or alterations in an individual’s deoxyribonucleic acid (DNA). Genotyping assays function by comparing the DNA of affected individuals with that of healthy ones to identify changes, thereby revealing specific genetic mutations or variations associated with a particular genetic disorder. For instance, in June 2023, Gene People, a UK-based registered charity organization dedicated to supporting individuals with genetic conditions, disclosed that one in every 25 children in the UK was affected by a genetic disorder. This impacted approximately 30,000 newborns and young children in the country, and over 2.4 million children and adults annually. Consequently, the increasing prevalence of genetic disorders is serving as a primary driver for the growth of the genotyping assay market.

How Is The Genotyping Assay Market Divided Into Its Major Segments?

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits

2) By Genotyping Services: Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

3) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

4) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

How Are Trends Impacting The Genotyping Assay Market?

Leading firms in the genotyping assay sector are innovating genomic research by creating CE-IVD certified assays to identify HIV-1 strains that resist treatment. The CE-IVD approved Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit is a Sanger sequencing method designed to analyze HIV-positive samples, pinpointing genetic mutations associated with resistance to standard antiretroviral drugs. As an illustration, in January 2023, Thermo Fisher Scientific, based in the U.S., introduced the CE-IVD certified Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This particular system identifies drug-resistant HIV-1 strains and offers distinct functionalities, such as evaluating genomic alterations, utilizing HIV RNA, pinpointing drug resistance mutations, employing the established Sanger sequencing method, and being suitable for clinical applications. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit contributes significant advantages by enhancing the detection of treatment-resistant HIV-1 strains, supplying pre-prepared reagents and controls, fulfilling regulatory standards, exhibiting strong performance attributes, and ensuring compatibility with current sequencing platforms and operational procedures.

Who Are The Prominent Organizations Shaping The Genotyping Assay Market?

Major companies operating in the genotyping assay market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs

Read the full genotyping assay market report here:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Which Region Is Forecast To Lead The Genotyping Assay Market In Terms Of Market Size?

North America was the largest region in the genotyping assay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genotyping Assay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

Browse Through More Reports Similar to the Global Genotyping Assay Market 2026, By The Business Research Company

Genotyping Global Market Report

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Reporter Gene Assay Global Market Report

https://www.thebusinessresearchcompany.com/report/reporter-gene-assay-global-market-report

Genetic Toxicology Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795